Movatterモバイル変換

[0]ホーム
URL:

Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Wolters Kluwer full text link Wolters Kluwer Free PMC article
Full text links

Actions

Share

.2010 Nov;151(2):378-383.
doi: 10.1016/j.pain.2010.07.024. Epub 2010 Aug 14.

Enhanced scratching evoked by PAR-2 agonist and 5-HT but not histamine in a mouse model of chronic dry skin itch

Affiliations

Enhanced scratching evoked by PAR-2 agonist and 5-HT but not histamine in a mouse model of chronic dry skin itch

T Akiyama et al. Pain.2010 Nov.

Abstract

Chronic itch is a symptom of many skin conditions and systemic disease, and it has been hypothesized that the chronic itch may result from sensitization of itch-signaling pathways. We induced experimental chronic dry skin on the rostral back of mice, and observed a significant increase in spontaneous hindlimb scratches directed to the dry skin. Spontaneous scratching was significantly attenuated by a PAR-2 antibody and 5-HT2A receptor antagonist, indicating activation of these receptors by endogenous mediators released under dry skin conditions. We also observed a significant increase in the number of scratch bouts evoked by acute intradermal injections of a protease-activated receptor (PAR)-2 agonist and serotonin (5-HT), but not histamine. We additionally investigated if pruritogen-evoked activity of dorsal root ganglion (DRG) neurons is enhanced in this model. DRG cells from dry skin mice exhibited significantly larger responses to the PAR-2 agonist and 5-HT, but not histamine. Spontaneous scratching may reflect ongoing itch, and enhanced pruritogen-evoked scratching may represent hyperknesis (enhanced itch), both potentially due to sensitization of itch-signaling neurons. The correspondence between enhanced behavioral scratching and DRG cell responses suggest that peripheral pruriceptors that respond to proteases and 5-HT, but not histamine, may be sensitized in dry skin itch.

Copyright © 2010 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest.

Figures

Fig. 1
Fig. 1
Spontaneous and pruritogen-evoked scratching behavior in AEW- and control mice. A: Bar graph plots mean number of scratch bouts recorded over a 30-min period without id injection (spontaneous) or following id injection of saline, histamine, the PAR-2 agonist SLIGRL-NH2, and 5-HT. Black bars: AEW dry skin treatment group; open bars: control water treatment; gray bars: naïve (untreated) group. Error bars: SEM. *: AEW group significantly different compared water and naïve groups for each stimulus condition (p<0.05 for all comparisons; repeated-measures ANOVA). #: significantly different compared to saline injection in water-treated group (p<0.05, unpaired t-test). B: Graph as in A, with vehicle-associated scratching subtracted. *: AEW group significantly different compared water group (p<0.05 for both; repeated-measures ANOVA). N.s.: after subtracting vehicle-associated scratching, there was no difference between AEW and W groups for histamine-evoked scratching behavior. (n =6–9/group).
Fig. 2
Fig. 2
Reduced spontaneous scratching following treatment with PAR-2 antibody or 5-HT2A antagonist ketanserin. A: PAR-2 antibody. AEW-treated mice received an id injection of PAR-2 antibody, or vehicle (IgG antibody) within the AEW treatment area. Graph plots mean number of scratch bouts recorded over 80 min observation period, beginning 5 min following antibody pretreatment. *: significantly different from vehicle; p<0.05, paired t-test, n=6/group). B: Ketanserin. AEW-treated mice received systemic ketanserin (3 mg/kg, ip) or vehicle (5% tween 80 in saline). The graph plots the mean number of scratch bouts recorded over an 80 min period, beginning 30 min after ketanserin or vehicle pretreatment. *: significantly different from vehicle; p<0.05, paired t-test, n=6/group).
Fig. 3
Fig. 3
Venn diagrams showing relative proportions of DRG cells responsive to histamine, PAR-2 agonist SLIGRL-NH2, and 5-HT, and various combinations, for each treatment group. A: Water-treated (W) controls (n=1,391 cells). 81%, 72% and 76% of histamine-, PAR-2 agonist- and 5-HTresponsive cells, respectively, were also activated by capsaicin. B: AEW (n=726). Proportions of histamine-, PAR-2 agonist-, and 5-HT-sensitive cells in AEW group were significantly greater compared to W group (p<0.05 for each, Fisher’s exact test). 66%, 58% and 85% of histamine-, PAR-2 agonist- and 5-HT-responsive cells, respectively, were also activated by capsaicin.
Fig. 4
Fig. 4
Individual examples of pruritogen-evoked responses of DRG cells. A: Histamine. Graph plots normalized 340/380 nm ratio vs. time for DRG cells from AEW-and W-treated mice. Histamine was applied at time 0:30 (red bar). B: PAR-2 agonist. C: 5-HT. Note larger responses of cells from AEW group to PAR-2 agonist and 5-HT.
Fig. 5
Fig. 5
DRG cells from AEW-treated mice show enhanced responses to PAR-2 agonist and 5-HT but not histamine. A: Histamine. Mean normalized ratiometric responses of DRG cells from each treatment group vs. time relative to histamine perfusion (red bar). Error bars: SEM. B: Mean peak response (% of baseline) of DRG cells to histamine for each treatment group. N.s.: no significant difference compared to W. C, E: as in A for PAR-2 agonist and 5-HT, respectively. D, F: as in B for PAR-2 agonist and 5-HT, respectively. *: significantly different compared to W (p<0.05, unpaired t-test). (n =14–23/group). Naïve data from cervical DRG cells (n=719) obtained from untreated mice. Dry skin treatment enhanced pruritogen-evoked scratching behavior in mice and responses of dorsal root ganglion cells, indicating peripheral sensitization of itch-signaling afferent fibers.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Akiyama T, Carstens MI, Carstens E. Excitation of mouse superficial dorsal horn neurons by histamine and/or PAR-2 agonist: potential role in itch. J Neurophysiol. 2009;102:2176–2183. - PMC - PubMed
    1. Akiyama T, Merrill AW, Zanotto K, Carstens MI, Carstens E. Scratching behavior and Fos expression in superficial dorsal horn elicited by protease-activated receptor agonists and other itch mediators in mice. J Pharmacol Exp Ther. 2009;329:945–951. - PMC - PubMed
    1. Akiyama T, Merrill AW, Carstens MI, Carstens E. Activation of superficial dorsal horn neurons in the mouse by a PAR-2 agonist and 5-HT: potential role in itch. J Neurosci. 2009;29:6691–6699. - PMC - PubMed
    1. Amadesi S, Nie J, Vergnolle N, Cottrell GS, Grady EF, Trevisani M, Manni C, Geppetti P, McRoberts JA, Ennes H, Davis JB, Mayer EA, Bunnett NW. Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia. J Neurosci. 2004;24:4300–4312. - PMC - PubMed
    1. Carstens E. Neurobiology of itch and pain: scratching for answers. In: Castro-Lopes J, editor. Current Topics in Pain: 12th World Congress on Pain. Seattle, WA: IASP Press; 2009. pp. 73–93.

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full text links
Wolters Kluwer full text link Wolters Kluwer Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

[8]ページ先頭
©2009-2025 Movatter.jp